Kezar Life Sciences (KZR)

• Market cap: $28.9M
• 1 day: -0.75%
• 5 days: -0.75%
• 1 month: 1.28%
• 3 months: -17.54%
• 6 months: -32.59%
• Year to date: -39.88%
• 1 year: -30.34%
• 5 years: -92.22%
• 10 years: -97.77%
• Sector: Healthcare
• Industry: Biotechnology

About: Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as Zetomipzomib (KZR-616), and KZR-261.

Employees: 55

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

38% more repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 8

2.01% more ownership

Funds ownership: 59.21% [Q1] → 61.22% (+2.01%) [Q2]

0% more funds holding in top 10

Funds holding in top 10: 1 [Q1] → 1 (+0) [Q2]

3% less capital invested

Capital invested by funds: $21.1M [Q1] → $20.5M (-$625K) [Q2]

2% less funds holding

Funds holding: 41 [Q1] → 40 (-1) [Q2]

25% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 4

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $1K